/PRNewswire/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, is proud to announce.
Enters into on an Exclusive Promotion and Distribution Agreement with Novartis for Distribution Rights to Seebri Breezhaler and Ultibro Breezhaler in CanadaZUG, Switzerland, Jan. 05, 2022 (GLOBE NEWSWIRE)
Ottawa, Ontario (Newsfile Corp. - November 23, 2021) - Innovative Medicines Canada (IMC) is pleased to announce that Cole C. Pinnow, President, Pfizer Canada ULC, has been elected Chair of its Board
/CNW/ - Today Novartis Pharmaceuticals Canada launches Not Another Minute, a campaign to bring Canadians together in the fight against cardiovascular disease.